NPF-Funded Research

Prevention of Cardiovascular Disease and Mortality in Patients with Psoriasis or Psoriatic Arthritis

Icon of a doctor - Kopa.

Principle Investigator: Joel Gelfand M.D., MSCE
University of Pennsylvania

Grant Mechanism: Psoriasis Prevention Initiative (Priority Mechanism)
Funding Amount: $1,500,000
Project Start Date: November 1, 2021
Project End Date: October 31, 2025
Status: Active
Keywords: Psoriasis, Psoriatic Arthritis, CVD Prevention, Patient Education

Project Summary:

This grant was made possible in part by contributions from Stacey Butler and Chip Newton.

Researcher Profile:

Dr. Joel Gelfand is the James J. Leyden, M.D. Endowed Professor in Clinical Investigation at the University of Pennsylvania. His research focuses on observational epidemiology in psoriasis and clinical trials in dermatologic diseases such as psoriasis, atopic dermatitis, cutaneous T cell lymphoma and acne/hidradenitis. Particular areas of interest include use of large medical records databases for epidemiologic and pharmacoepidemiologic studies in skin diseases and the design of efficient phase II trials for new indications of existing drugs and alternative medicines for the treatment of skin disease. Current, large ongoing projects include a prospective population-based cohort study of 8,000 psoriasis patients to evaluate cardiovascular risk and the development of the Dermatology Clinical Effectiveness Research Network (DCERN) to conduct comparative effectiveness studies in psoriasis and other dermatological diseases. Dr. Gelfand serves as a member of the NPF COVID-19 Task Force, and oversees the PCORI LITE Study, in partnership with the NPF.

Impact of NPF-Funded Research

The NPF has awarded over $30 million in research funding in recent years, with immeasurable impact on our community.

Read more

We Need Your Help

With your gift we can fund even more research to get better treatment and diagnostic options and someday, a cure.

Help fund critical research

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2022 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.